Michael S. Rafii, MD, PhD
|Title(s)||Associate Professor Of Clinical Neurology|
|Address||ATR 9860 Mesa Rim Road|
Health Sciences Campus
San Diego CA 92121
|Phone||+1 858 964 0638|
|LuMind Down Syndrome Research Foundation||2016||David Cox Award|
|The Johns Hopkins Hospital||2006||Preziosi Outstanding Neurology Resident Award|
|The Johns Hopkins Hospital||2006||Alpha Omega Alpha |
|The Johns Hopkins University/Sinai Hospital||2003||Intern of the Year|
|Brown University School of Medicine||2002||Aronson Prize for Excellence in Neuroscience|
Michael Rafii is Medical Director of the Alzheimer’s Therapeutic Research Institute and Associate Professor of Neurology at the Keck School of Medicine. He received his MD and PhD degrees from Brown University and conducted neurogenetics research at Harvard Medical School. He completed his residency in Neurology at the Johns Hopkins Hospital and fellowship in Neurodegenerative diseases at the University of California, San Diego.
As a physician-scientist, Dr. Rafii’s research program focuses on understanding the genetic form of Alzheimer's disease that occurs in persons with Down syndrome. He is Principal Investigator of the NIH-funded Alzheimer’s Clinical Trials Consortium - Down Syndrome (ACTC-DS). Dr. Rafii also leads the ATRI Medical Safety Section which provides oversight to ATRI’s portfolio of multi-center clinical trials. He serves as a scientific reviewer for the NIH and the Alzheimer's Association. Dr. Rafii’s work has been featured in the New York Times, Chicago Tribune, Wall Street Journal and National Public Radio (NPR).
Previously, Dr. Rafii served as Medical Director of the Alzheimer’s Disease Cooperative Study, Director of the Memory Disorders Clinic, Founding Director of the Adult Down Syndrome Clinic, Director of the Comprehensive Alzheimer’s Program, Director of the Adult Neurology Residency Training program and Associate Professor of Neurology at the University of California, San Diego.